Labour Analgesia; Comparing a Combinations of Either Fentanyl or Bupivacaine With Intrathecal Morphine
Information source: Makerere University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Labor Pain
Intervention: Intrathecal morphine with fentanyl (Drug); Intrathecal morphine with bupivacaine (Drug)
Phase: N/A
Status: Completed
Sponsored by: Makerere University Official(s) and/or principal investigator(s): Andrew Kintu, M.med, Study Director, Affiliation: Department of Anesthesia and Critical Care, Makerere University, College of Health Sciences, Kampala,Uganda Timothy Muyimbo, M.med, Principal Investigator, Affiliation: Department of Anesthesia and Critical Care, Makerere University, College of Health Sciences, Kampala,Uganda Fred Bulamba, M.med, Study Chair, Affiliation: Department of Anesthesia and Critical Care, Makerere University, College of Health Sciences, Kampala,Uganda
Summary
This study is aimed at evaluating single short spinal technique as a form of labour
analgesia in a setting where more expensive and labor intensive techniques are not
feasible. The study will examine the safety and efficacy of two drug combinations
(intrathecal morphine+fentanyl vs intrathecal morphine+bupivacaine) through a randomized
control trial.
The investigators hypothesize that a single shot of either intrathecal morphine plus
fentanyl or intrathecal morphine plus bupivacaine achieve analgesia and are safe in
parturients experiencing normal labour.
Clinical Details
Official title: Evaluation Of Efficacy And Safety Of Labour Analgesia By Intrathecal Morphine With Fentanyl Compared To Morphine With Bupivacaine In Mulago Hospital: A Double-blinded Randomized Control Trial
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Primary outcome: Duration of analgesia
Secondary outcome: APGAR scoreMaternal side effects (composite)
Eligibility
Minimum age: 14 Years.
Maximum age: 60 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Parturients with singleton pregnancy
- Emancipated minors
Exclusion Criteria:
- Those who declined.
- Parturients with any identified complication of labour like preeclampsia, severe
cardiac disease or previous operative delivery.
- Sepsis or wound at site of spinal injection.
- Allergy to any of the study drugs elicited from history.
Locations and Contacts
Additional Information
Starting date: January 2014
Last updated: July 12, 2015
|